Top of page

Student/Staff Portal
Global Site Navigation

School of Nursing and Midwifery

Local Section Navigation
You are here: Main Content

Maternal health is often framed in terms of physical wellbeing with a strong focus on prenatal care, safe delivery and postpartum recovery.

Tuesday, 17 November 2026

Tags:

by Rachel Granger and Mary Steen. (Article courtesy of ANMJ , Volume 29, No.3, Oct-Dec 2026)

Group B Streptococcus (GBS) is a common bacterium, found in 20-30% of adult gastrointestinal and reproductive tracts.1-3

Though often asymptomatic in the antenatal period, the concern for pregnant women relates to ascending infection and the potential for vertical transmission to their fetus/neonate once amniotic/chorionic membranes rupture.1,2 In Australia, global screening is recommended at approximately 36 weeks of pregnancy, with intrapartum intravenous antibiotic prophylactic (IAP) administration recommended as gold standard care.4

Antimicrobial use is among the biggest global threats to healthcare; between 2015–2050, 10,430 Australians are predicted to die due to antimicrobial resistance (AMR).5 In 2019, AMR was directly responsible for 1.27 million deaths globally.6 AMR impacts the ability to treat infections, and increases the risks associated with medical procedures.6 In 2021, Antimicrobial Use and Resistance in Australia (AURA) called for “urgent improvement strategies”,5 particularly in hospital settings, to improve appropriate antimicrobial use. The National Safety and Quality in Health Service (NSQHS) standards include ‘Preventing and Controlling Infections’ standard which promotes the prevention of infections,7 however Australian antibiotic use continues to be much higher than our global counterparts.8

In Western Australia, only 0.03% of babies born to a GBS positive mother may develop early onset GBS (EOGBS) sepsis, however the recommendation is for all GBS positive mothers receive IAP.4 Midwives and nurses, as uniquely placed champions of primary healthcare interventions, must assess whether there is more we can do to protect our mothers from increasing AMR, while safeguarding our vulnerable babies from EOGBS. Eradicating GBS by the time of routine screening would significantly reduce the use of IAP.

Antenatal probiotic supplementation promotes the proliferation of Lactobacillus in the vaginal microbiome and may be protective against pathogenic bacteria. An abundance of one species of Lactobacillus increases the release of lactic acid, increasing acidity of the vagina, creating an environment which cannot sustain pathogenic life. Probiotic use is considered “non-invasive and [a] cost-effective approach to support women’s health and prevent obstetric complications”.9,10 Systematic reviews of probiotic use and the impact on GBS status by time of birth continually emphasise the need for large scale, multicentre randomised controlled trials (RCT); given the ongoing evidence, the national and global goals for reduced AMR, and the number of women exposed to IAP for a relatively low risk of EOGBS in the neonate, we argue the time for this RCT is now.

Authors

  • Rachel Granger, BA MMid, Registered Midwife, North Metropolitan Health Service, Perth, Western Australia
  • Professor Mary Steen, OBE RGN RM BHSc PGCRM PGCertMWSDP PGDipMH PGDipHE MCGI PhD, Professor of Maternal and Family Health, Edith Cowan University Perth, Western Australia

References

  1. Fang S B. Can the administration of probiotics in pregnant mothers reduce Group B streptococcus maternal colonization and mother-to-infant transmission? Pediatrics & Neonatology. 2024 Mar; 65(2): 109-110. https://www. pediatr-neonatol.com/article/S18759572(24)00018-4/fulltext doi:10.1016/j. pedneo.2024.002.001
  2. Farr A, Sustr V, Kiss H, Rosicky I, Graf A, Makristathis A, Foessleitner P, & Petricevic L. Oral probiotics to reduce vaginal group B streptococcal colonization in late pregnancy. Scientific Reports. 2020; 1019745. https:// www.nature.com/articles/s41598-02076896-4#citeas doi:10.1038/s41598020-76896-4
  3. Hanna M, & Noor A. Streptococcus Group B. StatPearls. 2025 Dec 1. https:// www.ncbi.nlm.nih.gov/sites/books/ NBK553143/
  4. Royal Australian and New Zealand College of Obstetrics and Gynaecology (RANZCOG). Maternal Group B Streptococcus in pregnancy: screening and management. 2022, Jul. https:// ranzcog.edu.au/wp-content/uploads/ Maternal-Group-B-Streptococcus-inPregnancy-Screening-Management. pdf
  5. Antimicrobial Use and Resistance in Australia (AURA). AURA 2021; Fourth Australian report on antimicrobial use and resistance in human health. Australian Commission on Safety and Quality in Health Care. 2021. https:// www.safetyandquality.gov.au/sites/ default/files/2021-09/aura_2021_-_ report_-_final_accessible_pdf_-_for_ web_publication.pdf
  6. World Health Organization (WHO). Antimicrobial Resistance. 2023. https:// www.who.int/news-room/fact-sheets/ detail/antimicrobial-resistance
  7. Australian Commission on Safety and Quality in Health Care. The National Safety and Quality in Health Service (NSQHS) Standards: Preventing and Controlling Infections Standard. 2026 Apr 29. https://www.safetyandquality. gov.au/standards/nsqhs-standards/ preventing-and-controllinginfections-standard
  8. Australian Commission on Safety and Quality in Health Care. New report on antimicrobial use and resistance in Australia. 2021 Aug 27. https:// www.safetyandquality.gov.au/sites/ default/files/resources/attachments/ media_release_-_aura_2021_new_ report_on_antimicrobial_use_ and_resistance_in_australia_-_27_ august_2021.pdf 
  9. Shiroda, M, Aronoff DM, Gaddy JA, & Manning SD. The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes. Microb Pathog. 2020; 148:104463. https://pmc.ncbi.nlm.nih.gov/ articles/PMC7683368/ doi: 10.1016/j. micpath.2020.104463
  10. Wu LY, Yang TH, Ou YC, & Lin H. The role of probiotics in women’s health: An update narrative review. Taiwan J Obstet Gynecol. 2024; 63(1): 29-36. https://www. sciencedirect.com/science/article/ pii/S1028455923003017?via%3Dihub doi:10.1016/j.tjog.2023.09.018

Share

Skip to top of page